Highlights
NASDAQ: CLBS       Caladrius Bio
Last Price Today's Change   Day's Range   Trading Volume
1.558   -0.032 (2.01%)  1.51 - 1.64  117,838

Overview

 
Avg Volume (4 weeks):149,300
4 Weeks Range:1.51 - 1.95
4 Weeks Price Volatility (%):
10.91%
52 Weeks Range:1.05 - 3.64
52 Weeks Price Volatility (%):
19.61%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Caladrius Biosciences Inc is a company developing cellular therapeutics to treat certain diseases. The company has internal specialized cell therapy clinical development expertise to select and develop early-stage cell therapy candidates with the intention of partnering these candidates post proof-of-concept in humans. The product portfolio pf the group includes, CLBS03, an ex vivo expanded polyclonal T regulatory cell therapy for the treatment of recent-onset type 1 diabetes in a enrolling Phase 2 trial.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1892  4082  275  3150 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 MGEN 1.17+0.65 
 TTNP 0.195+0.067 
 GE 7.675+0.575 
 LK 1.38+1.38 
 AAPL 113.235-3.365 
 SQQQ 24.03+1.97 
 NIO 27.825-0.615 
 OAS 0.155-0.014 
 NAKD 0.087-0.005 
 AMD 76.51-2.37